Zdrowie i gospodarka · 07/10/2022

FDA Announces Draft Guidance for Industry on Facility Readiness for Generic Drug Applications

The FDA has released a draft guidance outlining how the agency will use facility readiness information to set goal dates for original abbreviated new drug applications submitted under the Federal Food, Drug, and Cosmetic Act, as part of the Generic Drug User Fee Amendments reauthorization.